Medicines for All awarded $18.7 million to increase global access to lifesaving medications
After a decade of providing global cost-saving processes for medications, the Central Virginia institute looks ahead to growing engagement with partners within each disease ecosystem.
Richmond-Petersburg region, collaborating as the Alliance for Building Better Medicine, secures $111 million over three months for U.S. based manufacturing of essential medicine
Alliance for Building Better Medicine, a coalition of public and private sector stakeholders in the Richmond-Petersburg region, and Governor Glenn Youngkin yesterday honored National Essential Medicine Shortage Awareness Day by announcing $111 Million has been invested by federal, state, local, and private supporters over the past three months to accelerate the development of the advanced pharmaceutical and manufacturing cluster emerging in Central Virginia.
Richmond-Petersburg region is a winner of the national Build Back Better Regional Challenge
The U.S. Department of Commerce's Economic Development Administration (EDA) today announced that public and private sector stakeholders in the Richmond-Petersburg region, working together as the Alliance for Building Better Medicine, will receive $52,942,702 as a winner of the national Build Back Better Regional Challenge.
Richmond-Petersburg regional coalition, including VCU, awarded $53 million in Build Back Better Regional Challenge
Virginia Commonwealth University, will receive nearly $53 million as one of 21 winners of the national Build Back Better Regional Challenge.
Research right now
A glance at some of the latest research projects at VCU, including VCU Engineering projects to improve air quality, save coral populations and expand availability of a potential COVID drug.
VCU’s Medicines for All Institute drives down production costs of molnupiravir, the first investigational pill to treat COVID-19
The Medicines for All Institute (M4ALL) in the Virginia Commonwealth University College of Engineering has developed low-cost manufacturing processes for molnupiravir, the first investigational pill to treat COVID-19.
U.S. Rep. Abigail Spanberger announces pharmaceutical readiness legislation at VCU’s College of Engineering
U.S. Rep. Abigail Spanberger spoke at the VCU College of Engineering to announce the introduction of legislation to create a strategic national stockpile of key ingredients used in essential generic medicines and to incentivize domestic manufacturing of these ingredients.
Medicines for All Institute quickly pivots to COVID-19 treatments
The Medicines for All Institute (M4ALL) has been developing innovative, cost-effective processes for making drugs that fight HIV, malaria and tuberculosis since it was established at the Virginia Commonwealth University College of Engineering in 2017.
VCU College of Engineering and partners develop plan to strengthen emerging business cluster
A coalition of regional economic development, private business and higher education leaders is mobilizing to build a global cluster of advanced pharmaceutical manufacturing, research and development in Richmond and Petersburg.
New leaders join VCU Engineering’s Medicines for All Institute
The Medicines for All Institute (M4ALL), based in the Virginia Commonwealth University College of Engineering, is expanding its efforts to improve access to health care across two divisions — one for global health and one for domestic initiatives — and has hired new executives to lead each.
